Oral administration of C. sativus extract (1 and 10 mg/kg, p.o.)and safranal in the OVA-induced murine model of asthma (in vitro) study, reduced iNOS levels and inflammatory cytokines such as; L-5 and IL-13 levels in the lung tissue. The gene discussed is NOS2; the disease is asthma.